ClinicalTrials.Veeva

Menu
R

Retina Consultants of Charleston | Ladson

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

QPI-1007
ranibizumab
AVD-104
BI 771716
Aflibercept

Parent organization

This site is a part of Retina Consultants of Charleston

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 6 total trials

A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) (SIGLEC)

Investigate the Safety, Pharmacokinetics, and Treatment effects of Single and Multi-dose of Intravitreal AVD-104 in participants with geographic atro...

Active, not recruiting
Macular Degeneration
Geographic Atrophy of the Macula
Drug: AVD-104
Drug: Avacincaptad

Researchers are looking for a better way to treat people who have macular edema secondary to retinal vein occlusion (RVO).In people with RVO, a blood...

Active, not recruiting
Macular Edema Secondary to Retinal Vein Occlusion
Drug: Aflibercept, VEGF Trap-Eye(Eylea, BAY86-5321)_2 mg
Drug: Sham

This study is open to people 50 years or older with an eye condition called geographic atrophy. The purpose of this study is to compare a medicine ca...

Begins enrollment this month
Macular Degeneration, Age-related
Geographic Atrophy
Drug: Pegcetacoplan
Drug: Sham comparator to BI 771716

Trial sponsors

A
Bayer logo
Boehringer Ingelheim logo
Genentech logo
Lilly logo
Q

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems